DNA microarrays provide a means to quantify tens of thousands of discrete sequences in a single assay. Among the most widespread uses of microarrays is expression profiling 1,2, which has found many ...

The pharmacogenomic testing service market is witnessing strong growth, driven by the increasing adoption of personalized medicine and the growing recognition of genetic factors in drug response.

A research team led by Minyoung Lee and Sunggyu Park of The Korea Institute of Materials Science (KIMS) Bio & Health ...

Asia-Pacific emerges as a key growth region. The global DNA diagnostics market is projected to grow from $13.2b in 2025 to ...

The use of microarrays to analyse gene expression on a global level has recently received a great deal of attention. There has been much speculation about the power of this approach in the analysis of ...

According to MarketsandMarkets™, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by ...

Dr. Lue Ping Zhao is a biostatistician with a background/experience in bioinformatics, epidemiology and genetics. He aims to accelerate the translation of big data technologies and findings to ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that studies featuring optical genome mapping (OGM) at the 2026 European Society of Human Genetics (ESHG) conference grew substantially compared ...

Background Wolf–Hirschhorn syndrome (WHS) is a contiguous gene deletion syndrome involving variable size deletions of the 4p16.3 region. Seizures are frequently, but not always, associated with WHS.